Thank You

2010 Resident Education Day:

“Communication Tools for OBGyn Residents”

Date: Friday, May 7, 2010

Place:                Thomas Jefferson University, Bluemle Life Science Building, Room 101

233 South 10^th Street (Corner of 10^th & Locust Streets),Philadelphia, PA  19107

(Parking available in Hamilton Building underground garage, 1001 Locust Avenue, you must bring your parking ticket for validation)

Agenda:            8:00 am– 8:45am – Registration, Breakfast,

Resident Bowl Qualifying Examination

(as many residents as would like to may take the morning qualifying exam,

but a maximum of 1 resident per program will qualify for the afternoon’s Bowl)

8:45am – 9:45am- Communicating with Adolescents:Teens Not Gone Wild

Anne Troy, MN, RN, FNP-BC Assistant Professor, LSU Medical Center

9:45am – 10:45am-Cross-Cultural Communication

Ana Núñez, MD Director, Women’s Health Education Program, Associate Professor of Medicine. Drexel University College of Medicine

10:45am-11:00am- Break

11:00am – 11:15am- S. Leon Israel Award and Resident Presentation

11:15am – 11:45am-Audience Response: Electronic Communication

11:45am – 12:45pm-Lunch at Hamilton Building

1:00pm – 2:00pm - Communicating for Safety: Patient Handoff

Daniel M. Feinberg, MD, FAAN, VP Clinical Excellence, Catholic Health East

2:00pm – 2:30pm -Resident Bowl

Learning Objectives

After attending the seminar the participant will be able to:

1. Discuss the rapidly advancing field of genetics and prenatal diagnosis; current screening and testing recommendations; as well as cutting edge technology and research.

2. Identify the maternal serum, ultrasound and carrier screening options which are currently available to preconceptional and pregnant patients.

3. Discuss the newer applications and technologies available in prenatal diagnosis, including microarray CGH and noninvasive prenatal diagnosis.

4. Recognize newer technologies and applications of ultrasonography in prenatal diagnosis and specifically fetal heart.

Contact Information

Drexel University College of Medicine

Office of Continuing Medical Education

1427 Vine Street, Suite 405, MS 1013, Philadelphia, PA 19102

Phone: 215-762-2580 • Fax: 215-762-2589

Drexel University College of Medicine is a separate not-for-profit subsidiary of Drexel University.

Plenary Session

7:00 – 7:50 a.m. Breakfast and Registration

7:45 – 8:00 a.m. Welcome and overview

Owen Montgomery, MD

Chairman, Department of Obstetrics and Gynecology

Drexel University College of Medicine

Ossie Geifman-Holtzman, MD

Drexel University College of Medicine Pregnancy, Genetics and Ultrasound Center of Philadelphia

8:00 – 9:30 a.m. 22q11.2 Syndrome: Implications for prenatal testing and counseling

A tribute to Dr. Angelo DiGeorge

Presentation and Panel Discussion

Moderator: Deborah A. Driscoll, MD University of Pennsylvania

Panelists: Beverly S. Emanuel, PhD Elaine H. Zackai, MD Elizabeth Goldmuntz, MD Donna M. McDonald-McGinn, MS, CGC The Children’s Hospital of Philadelphia

9:30 – 10:45 a.m. Current trends in invasive prenatal diagnosis — from the bedside to the laboratory

Ronald Wapner, MD Columbia University Medical Center

10:45 – 11:00 a.m. BREAK

11:00 – 12:00 p.m. Assisted reproductive technology and congenital anomalies

David Keefe, MD, New York University

12:00 – 1:00 p.m. Commercial interests vs. public good in genetic testing and prenatal diagnosis

David H. Ledbetter, PhD Emory University School of Medicine

1:00 p.m. LUNCH

“Highlights in

Prenatal Diagnosis for

practitioners caring for pregnant women.”Update Conference Agenda • Friday, June 4, 2010

Breakout Sessions

Genetics

1:45 – 2:30 p.m. Cutting edge prenatal diagnosis — CGH array and non invasive prenatal diagnosis

David H. Ledbetter, PhD

Emory University School of Medicine

Ossie Geifman-Holtzman, MD Drexel University College of Medicine

2:30 – 3:15 p.m. The clinical conundrum of psychotropic medication use in pregnancy

C. Neill Epperson, MD, University of Pennsylvania

3:15 – 3:30 p.m. BREAK

3:30 – 4:15 p.m. Thrombophilia — what’s on your panel?

James Airoldi, MD, MPH

St. Luke’s Hospital and Health Network

Ultrasound

1:45 – 2:30 p.m. The fetal anatomy — fetal structural and anomaly detection at 9–16 weeks

Ilan Timor-Tritsch, MD, New York University

2:30 – 3:15 p.m. Pitfalls and artifacts in 3Dultrasound

Israel Shapiro, MD, Technion, Haifa, Israel

3:15 – 3:30 p.m. BREAK

3:30 – 4:15 p.m. Doppler studies — their clinical utility in maternal and fetal disease

Stuart Weiner, MD, Thomas Jefferson University

Plenary Session

4:15 – 5:00 p.m. 3-4 dimensional ultrasound — gimmick or breakthrough?

Israel Shapiro, MD, Technion, Haifa, Israel

5:00 p.m. Wrap-up, evaluation and adjournment

Fetal Echo Course • Saturday, June 5, 2010

7:30 – 8:15 a.m. Breakfast and Registration

8:15 – 8:30 a.m. Welcome and overview

Ossie Geifman-Holtzman, MD Drexel University College of Medicine

8:30 – 9:30 a.m. Fetal ECHObasics — Normal views in fetal echocardiography: principle and techniques

Israel Shapiro, MD, Technion, Haifa, Israel

9:30 – 10:30 a.m. Indications and genetics implications for fetal ECHO

Dennis Wood, RDMS, RDCS, RCPT

Thomas Jefferson University

10:30 – 10:45 a.m. BREAK

10:45 – 11:45 a.m. Fetal cardiac arrhythmias — their diagnosis and their management

Jack Rychik, MD, The Children’s Hospital of Philadelphia

11:45 – 12:45 p.m. Cardiovascular Doppler: normal, fetal disease and twins

Dennis Wood, RDMS, RDCS, RCPT

Thomas Jefferson University

12:45 – 1:30 p.m. Lunchand panel discussion with the experts

1:30 – 2:30 p.m. Complex heart disease in the fetus — diagnosis and management

Jack Rychik, MD, The Children’s Hospital of Philadelphia

2:30 – 3:30 p.m. 3-4 dimensional techniques — a glance at new 3-dimensional techniques in fetal ECHOIsrael Shapiro, MD, Technion, Haifa, Israel

3:30 – 4:30 p.m. Teaching and presentation of complicated cases

Dennis Wood, RDMS, RDCS, RCPT

Thomas Jefferson University

Israel Shapiro, MD, Technion, Haifa, Israel

Jack Rychik, MD, The Children’s Hospital of Philadelphia

4:30 p.m. Wrap-up, evaluation and adjournment

“Best group of speakers in the field of prenatal genetics and ultrasound diagnosis.”

Plan taxes too much, spends too much, and fails to put Pennsylvania on a path to prosperity

Harrisburg, PA – With state budget impasse finally over, Commonwealth Foundation President Matthew J. Brouillette released the following statement: 
“This budget is highly irresponsible given the recession and the state’s mountain of unfunded liabilities. It taxes too much, spends too much, and puts Pennsylvania on an unsustainable path to the future. Even if our economy recovers to an unprecedented level in the next two years, there is no way it could produce enough tax revenue to bridge the budgetary canyon that will emerge when the federal stimulus money drops in 2010 and then vanishes in 2011, and the pension obligations for school employees and state workers come due in 2012. please read the rest at: http://www.commonwealthfoundation.org/research/detail/this-is-the-budget-we-waited-for

Thanks

Albert

H1N1 Vaccines En Route to Pennsylvania (from the PMS site)

H1N1 influenza vaccines are on their way to Pennsylvania. The Pennsylvania Department of Health (DOH) reported that it placed orders for the vaccine on Wednesday, Sept. 30.

First to arrive in early October will be live attenuated influenza vaccine (LAIV), a nasal spray vaccine that retails under the name FluMist.

Since this vaccine cannot be given to everyone at high-risk of complications from influenza, DOH will first target school children 5 to 9 years old and, to a lesser degree, college students. The DOH reported that 70 percent of illness in the state has been seen in children and young adults ages 5 to 24.

The initial rounds of vaccine will be channeled to the areas of the state with the highest rate of disease: the southwest, southeast, and north central.

Injectable, inactivated vaccines will follow later in October. Physicians should target those groups recommended by the Advisory Committee on Immunization Practices.

“We need your cooperation in assuring the vaccine reaches individuals in the prioritized groups, especially early in the process, as this makes the greatest impact on reducing disease transmission and protecting individuals at higher risk of influenza complications,” said Stephen Ostroff, MD, the state’s acting Physician General.

Physicians who wish to distribute the H1N1 vaccine must register with the DOH.

Adapted form ACOG site

• Pregnant women are at increased risk for severe complications and death from the 2009 H1N1 influenza virus (formerly called “novel H1N1 flu” or “swine flu”).

• Early treatment (i.e., within 48 hours of illness onset) with influenza antiviral medications is recommended for pregnant women with suspected influenza illness. Clinicians should not wait for test results to initiate treatment since these medications work best if started as early as possible after illness onset http://www.cdc.gov/H1N1flu/pregnancy/antiviral_messages.htm. Moreover, rapid diagnostic tests for influenza have variable sensitivities for detecting the 2009 H1N1 influenza virus (10-70%). A negative rapid test does NOT exclude the possibility of infection with 2009 H1N1 influenza http://www.cdc.gov/h1n1flu/guidance/diagnostic_tests.htm.

• Pregnancy has been identified as a co-morbid condition needing contact with a health care provider. CDC states that all pregnant women should be counseled about the early signs and symptoms of influenza infection and advised to immediately call for evaluation if clinical signs or symptoms develop. Since rapid access to antiviral medications is essential, health care providers who care for pregnant women should develop methods to ensure that treatment can be started quickly after symptom onset. This includes ensuring rapid access to telephone consultation and clinical evaluation for pregnant women. Also, consider empiric treatment of pregnant women based on telephone contact if hospitalization is not indicated and if this will substantially reduce delay before treatment is initiated.

• The Centers for Disease Control and Prevention (CDC) and ACOG recommend that pregnant women be vaccinated for both the 2009 H1N1 influenza virus and the seasonal flu [http://www.acog.org/publications/pdfs/co305.pdf]. Pregnant women can be vaccinated for influenza during any trimester. The H1N1 vaccine can be given postpartum, providing indirect protection for infants less than 6 months old, and to breastfeeding women. Q & As on H1N1 for pregnant women are available at http://www.cdc.gov/h1n1flu/pregnancy.

• Some pregnant women are concerned about mercury (thimerosal) in vaccines as a risk for being vaccinated. However, there is no evidence that thimerosal (used as a preservative in vaccine packaged in multi-dose vials) is harmful to pregnant women or the fetus. Because of their concern, however, there will be preservative-free seasonal and H1N1 vaccine available in single dose syringes for pregnant women and young children. See CDC’s Q & A on thimerosal and pregnant women at http://www.cdc.gov/h1n1flu/vaccination/pregnant_qa.htm.

• The H1N1 vaccine is expected to be available in October, initially in a nasal spray and then in vials for injection. The seasonal flu vaccine that is currently available in most areas is also available in a nasal spray. However, the nasal spray is a live attenuated virus and should NOT be used in pregnant women. Pregnant women should get the “flu shot” for both H1N1 and seasonal flu. See CDC’s guidelines at http://www.cdc.gov/h1n1flu/pregnancy.

• As health care workers, obstetrician-gynecologists and their staff are as much a priority for being vaccinated against H1N1 as are pregnant women http://www.cdc.gov/h1n1flu/vaccination/acip.htm.

• The government is providing the H1N1vaccine and administration supplies for free so providers cannot charge for that but can charge for administering the vaccine. AMA just issued new CPT codes specific to the H1N1 vaccine product that are effective immediately www.ama-assn.org/go/h1n1. The new codes are: ??90470 — H1N1 immunization administration (intramuscular, intranasal), including counseling when performed ?90663 — Influenza virus vaccine, pandemic formulation, H1N1

• CDC’s National Ob Grand Rounds on H1N1 influenza and pregnancy address many key treatment, testing and vaccination issues. Continuing education credit hours are provided with the archive of the September 29 Grand Rounds conference call at http://emergency.cdc.gov/coca/updates/2009/2009sep28.asp.

• On September 23 ACOG, SMFM, AAP, ACNM and other health and education organizations released [http://www.marchofdimes.com/aboutus/49267_61364.asp] a joint information message for pregnant women about H1N1 and influenza [http://www.acog.org/departments/dept_notice.cfm?recno=20&bulletin=4913].

ACOG’s web site is frequently updated as new H1N1 guidance and other resources are released, so ob-gyns should bookmark it and check back often. ACOG’s home page features late-breaking information on H1N1 [http://www.acog.org] and links to ACOG’s H1N1 page that includes pertinent guidelines, resources and updates for ob-gyns and pregnant women [http://www.acog.org/departments/dept_notice.cfm?recno=20&bulletin=4866].

CEO, USF Health

Dean, College of Medicine

University of South Florida

1)      To understand what aspects of medical education which have been underemphasized will be important for the future of health care 

2)      To understand the educational and selection mechanisms that have created biases which limit physicians and physician leaders from being successful in a changing healthcare environment

3)      To realize the power of creative thought in assisting health care leaders as they confront an ever changing environment

4)      To separate the myths from the realities concerning the skill sets necessary to succeed in a healthcare future based on quality, service and technology

5)      To understand how other entities—business leaders, entrepreneurs, managed care organizations—view physicians and the opportunities in health care on the horizon, and what they are doing about it.

6)      To empower patients and business leaders to understand the role of complexity, teamwork and corporate best practices in ensuring patient safety

7)      To identify new “report cards” that are being developed for hospitals and healthcare providers and to recognize the business community’s role in demanding quality excellence

8)      To understand the most likely changes associated with healthcare reform and how that may affect you as a doctor, patient, businessperson or entrepreneur.  Given those changes there may be elements of all four in your successful future.